Apraxia
MONDO:0000665Apraxia is a neurological disorder characterized by the inability to perform tasks or movements, despite having the desire and physical ability to perform them. It is caused by damage to the brain, especially the parietal lobe, and can arise from many diseases, tumors, a stroke, or traumatic brain injury. In some cases it is present from birth. There are several types of apraxia, which may occur alone or together. These include: Buccofacial or orofacial apraxia is the inability to carry out facial movements on demand. This may include licking the lips, sticking out the tongue, whistling, coughing, or winking. Ideational apraxia is the inability to carryout learned, complex tasks with multiple, sequential movements. This may include dressing, eating, and bathing. Ideomotor apraxia is the inability to perform a learned task (such as using a tool) or communicate using gestures (like waving good-bye). Limb-kinetic apraxia is the inability to make fine, precise movements with an arm or leg. This may include buttoning a shirt or tying a shoe. Verbal apraxia is difficulty coordinating mouth and speech movements. Verbal apraxia may be acquired or present from birth. Constructional apraxia is the inability to copy, draw, or construct simple figures. Oculomotor apraxia is difficulty moving the eyes on command. Treatment of apraxia may include physical, speech, or occupational therapy. If apraxia occurs as a symptom of another disorder, treatment should be directed to the underlying condition.
Also known as: Apraxias, dyspraxia
40 clinical trials for this condition and its sub-types, 17 tagged with Apraxia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Apraxia
-
Gait apraxia 23 trials
-
Ideomotor apraxia 0 trials
-
Can targeted exercise help older diabetics stay steady on their feet?
Disease control Not yet recruitingThis trial aims to find out whether a standard exercise program (Otago) or a specialized balance training that engages multiple senses (multisensory integration) is more effective at improving balance and walking in older adults with type 2 diabetes. Participants, aged 65 to 75, …
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Implanted nerve stimulator aims to restore walking after spinal injury
Disease control Not yet recruitingThis study tests a device called the ReWire system, which is implanted to stimulate the vagus nerve during leg rehabilitation. The goal is to see if this paired stimulation can safely improve walking in people with chronic, incomplete spinal cord injury. The trial involves 20 par…
Sponsor: The University of Texas at Dallas • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a fish oil supplement help kids with speech apraxia?
Symptom relief Not yet recruitingThis study tests an investigational drug called Omega-DEK plus L-carnitine in 34 children aged 3 to 6 with childhood apraxia of speech (CAS). The study lasts 20 weeks and first gives everyone the treatment, then randomly assigns some to a placebo to see if the treatment helps mai…
Phase 2 • Sponsor: Claudia R. Morris • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Rhythm and recovery: music may boost therapy for kids with CP
Symptom relief Not yet recruitingThis study will test whether adding music therapy to standard physical therapy helps children with spastic cerebral palsy improve their concentration and walking. Forty children aged 5 to 7 will either receive physical therapy alone or physical therapy combined with rhythmic musi…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
HIIT workouts may boost mobility and brain function in MS patients
Symptom relief Not yet recruitingThis study will test whether high-intensity interval training (HIIT) on a stationary bike can improve walking, balance, and thinking in people with multiple sclerosis (MS). Forty adults with mild to moderate MS will be randomly assigned to either HIIT or moderate-intensity contin…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC